Does HRT cause breast cancer? What the numbers actually say

This is the fear that did the most damage, so it's worth being precise. The breast-cancer signal that drove the post-2002 panic came from one arm of the Women's Health Initiative — estrogen plus a synthetic progestin — and it was reported as roughly a 24-26% relative increase. The experts' core point is that a relative increase on a rare event is still a small absolute number: it works out to roughly one extra case per 1,000 women per year. The estrogen-alone arm showed no increased breast-cancer risk at all.

Attia built this case with the field's leading voices — Avrum Bluming and Carol Tavris ("Estrogen Matters"), and the WHI's own lead investigator JoAnn Manson — arguing that cardiovascular disease, not breast cancer, is the dominant cause of death in women, and that estrogen may help address it. Hyman covered the same numbers with OB/GYN Dr. Sharon Malone. Huberman conveys the reframe via Dr. Mary Claire Haver but is the most cautious in his own voice, explicitly flagging concerns around estrogen-dependent conditions.

This is why the FDA's November 2025 decision specifically removed the breast-cancer boxed warning (along with cardiovascular disease and dementia) — while keeping the endometrial-cancer warning for systemic estrogen-only therapy in women with a uterus. The breast-cancer headline, in other words, is the one the modern reading pushes back on hardest.

The honest caveat: "small absolute risk in aggregate" is not "zero risk for you." A personal or strong family history of hormone-sensitive cancer is exactly the situation that requires individualized, specialist shared decision-making — a history of cancer does not automatically settle the question in either direction. This is a conversation with a menopause-trained physician, not a self-prescribed decision.